40 min listen
Microsoft, weight loss drug sales, and GSK profits surge
Microsoft, weight loss drug sales, and GSK profits surge
ratings:
Length:
9 minutes
Released:
Jan 31, 2024
Format:
Podcast episode
Description
In today's episode, Ian King speaks with Dan Ives - managing director of the brokerage and advisory firm Wedbush Securities - to discuss Microsoft's revenues and AI.Ian Johnston, global pharmaceutical correspondent at the Financial Times, discuses sales of popular weight loss drug 'Wegvoy', made by Novo Nordisk - as they say their sales almost quadrupled last year.And, Ian discusses GSK's operating profit of £8.8billion for 2023 with strong selling medicines including its HIV and shingles medication.
Released:
Jan 31, 2024
Format:
Podcast episode
Titles in the series (100)
Inflation soars, lockdown hits pubs and some Bank of England jobs move north: Jumps in the price of energy and clothing have led to a big increase in the cost of living, as the Office for National Statistics says UK inflation doubled to 1.5% last month. Ian is joined by HSBC Economist, Liz Martins. Also in today's episode, pub... by The Ian King Business Podcast